Contineum Therapeutics Price Target Cut to $24.00/Share From $26.00 by Jones Trading
Ratings actions from Benzinga
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Ratings actions from Benzinga
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.